Tamyra A. Toole
General Counsel at RUBIUS THERAPEUTICS
Profile
Tamyra A.
Toole is currently the Vice President-Regulatory Affairs at Rubius Therapeutics, Inc. She previously worked as the Senior Director-Regulatory Affairs at NitroMed, Inc. from 2005 to 2008 and as the VP-Regulatory Affairs & Quality Assurance at Infinity Pharmaceuticals, Inc. from 2008 to 2017.
Ms. Toole has a graduate degree from The Catholic University of America and an undergraduate degree from Villanova University.
Tamyra A. Toole active positions
Companies | Position | Start |
---|---|---|
RUBIUS THERAPEUTICS | General Counsel | 01/06/2018 |
Former positions of Tamyra A. Toole
Companies | Position | End |
---|---|---|
INFINITY PHARMACEUTICALS, INC. | General Counsel | 01/01/2017 |
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | General Counsel | 01/05/2008 |
Training of Tamyra A. Toole
The Catholic University of America | Graduate Degree |
Villanova University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
INFINITY PHARMACEUTICALS, INC. | Health Technology |
Private companies | 2 |
---|---|
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Health Technology |
Rubius Therapeutics, Inc.
Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Stock Market
- Insiders
- Tamyra A. Toole